MedPath

Platelet Rich Plasma Study in Lower Extremity Bypass Surgery

Completed
Conditions
Atherosclerosis
Registration Number
NCT00517452
Lead Sponsor
Lawson Health Research Institute
Brief Summary

The use of platelet rich plasma will decrease wound infection postop.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
81
Inclusion Criteria
  • Vascular surgical patients scheduled for elective lower extremity bypass surgery,aortoiliac revascularizations and endovascular AAA repair requiring a groin incision
Exclusion Criteria

Patients requiring emergent procedures, unable to give informed consent

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Wound healing4- 6 weeks post op
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath